Trends in five-year survival of patients discharged after acute myocardial infarction. 2006

Iqbal R Bata, and Ronald D Gregor, and Hermann K Wolf, and Brenda Brownell
Department of Medicine, Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada.

BACKGROUND It has previously been shown that the increased use of therapeutic intervention may not reduce patient fatality if there is a simultaneous increase in case severity. The present study was designed to extend the relationship between case severity and therapeutic interventions to long-term survival in the same study population. OBJECTIVE To compare five-year survival of patients discharged after acute myocardial infarction from 1984 to 1988 and from 1989 to 1993, and to evaluate possible reasons for survival differences. METHODS The present study was population-based. Survival time was determined by record linkage into the Canadian Mortality Database. Association of five-year survival with patient characteristics, in-hospital treatment and discharge medications was assessed by logistical regression analysis. Case severity was calculated as the probability of death within five years, given the patient profile and excluding any interventions. RESULTS Between the two study periods, most patient characteristics and treatment intensity changed, but case severity for the study population remained constant. Five-year survival improved from 74.8% to 79.2% (P(chi2)=0.001). The improvement was adequately described by the combination of changes in patient profile and treatment without residual period effect (P(goodness-of-fit)=0.752). The treatments significantly associated with five-year survival were coronary artery bypass graft surgery (OR 2.74; 95% CI 1.86 to 4.05), percutaneous coronary intervention (OR 2.63; 95% CI 1.67 to 4.14) and thrombolysis (OR 1.98; 95% CI 1.50 to 2.62) during admission, as well as acetylsalicylic acid (OR 1.39; 95% CI 1.15 to 1.68) or beta-blocker (OR 1.60; 95% CI 1.34 to 1.92) prescription at discharge. CONCLUSIONS Changes in patient profile did not affect long-term prognosis; instead, treatment modalities accounted for the observed improvement in five-year survival.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007902 Length of Stay The period of confinement of a patient to a hospital or other health facility. Hospital Stay,Hospital Stays,Stay Length,Stay Lengths,Stay, Hospital,Stays, Hospital
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009674 Nova Scotia A province of eastern Canada, one of the Maritime Provinces with NEW BRUNSWICK; PRINCE EDWARD ISLAND; and sometimes NEWFOUNDLAND AND LABRADOR. Its capital is Halifax. The territory was granted in 1621 by James I to the Scotsman Sir William Alexander and was called Nova Scotia, the Latin for New Scotland. The territory had earlier belonged to the French, under the name of Acadia. (From Webster's New Geographical Dictionary, 1988, p871 & Room, Brewer's Dictionary of Names, 1992, p384)
D010351 Patient Discharge The administrative process of discharging the patient, alive or dead, from hospitals or other health facilities. Discharge Planning,Discharge Plannings,Discharge, Patient,Discharges, Patient,Patient Discharges,Planning, Discharge,Plannings, Discharge
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.

Related Publications

Iqbal R Bata, and Ronald D Gregor, and Hermann K Wolf, and Brenda Brownell
January 1977, Materia medica Polona. Polish journal of medicine and pharmacy,
Iqbal R Bata, and Ronald D Gregor, and Hermann K Wolf, and Brenda Brownell
January 2007, European journal of epidemiology,
Iqbal R Bata, and Ronald D Gregor, and Hermann K Wolf, and Brenda Brownell
February 1980, British heart journal,
Iqbal R Bata, and Ronald D Gregor, and Hermann K Wolf, and Brenda Brownell
July 1979, The American journal of medicine,
Iqbal R Bata, and Ronald D Gregor, and Hermann K Wolf, and Brenda Brownell
October 1975, European journal of cardiology,
Iqbal R Bata, and Ronald D Gregor, and Hermann K Wolf, and Brenda Brownell
June 1999, European heart journal,
Iqbal R Bata, and Ronald D Gregor, and Hermann K Wolf, and Brenda Brownell
February 2024, Orvosi hetilap,
Iqbal R Bata, and Ronald D Gregor, and Hermann K Wolf, and Brenda Brownell
October 2020, Kardiologia polska,
Iqbal R Bata, and Ronald D Gregor, and Hermann K Wolf, and Brenda Brownell
January 2021, Journal of the American Heart Association,
Iqbal R Bata, and Ronald D Gregor, and Hermann K Wolf, and Brenda Brownell
June 1976, British medical journal,
Copied contents to your clipboard!